These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 17084128

  • 1. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life.
    Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP.
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1509-15. PubMed ID: 17084128
    [Abstract] [Full Text] [Related]

  • 2. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN.
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [Abstract] [Full Text] [Related]

  • 3. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G.
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [Abstract] [Full Text] [Related]

  • 4. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy.
    McCoy AA, Fox MA, Schaubel DE, Ayyangar RN.
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127
    [Abstract] [Full Text] [Related]

  • 5. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS, Yablon SA, Hayes A.
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [Abstract] [Full Text] [Related]

  • 6. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM.
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intrathecal baclofen for spastic hypertonia from stroke.
    Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN.
    Stroke; 2001 Sep; 32(9):2099-109. PubMed ID: 11546903
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
    Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS, Dutch Study Group on Child Spasticity.
    Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
    [Abstract] [Full Text] [Related]

  • 12. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children.
    Albright AL, Awaad Y, Muhonen M, Boydston WR, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K.
    J Neurosurg; 2004 Aug; 101(1 Suppl):64-8. PubMed ID: 16206974
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A, Sorbello M, Fazzio S, Zingale SF, Bucolo GE, Pittalà G, Castiglione A, Patti F, Mangiameli S.
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [Abstract] [Full Text] [Related]

  • 15. Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales.
    Bramanti P, D'Aleo G, Rifici C, Alagna A, Cannata A, Sessa E, Di Bella P, Marra G.
    Funct Neurol; 2004 Oct; 19(4):227-31. PubMed ID: 15776790
    [Abstract] [Full Text] [Related]

  • 16. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D, Quera Salva MA, Roche N, Benyahia S, Bohic M, Denys P, Bussel B, Lofaso F.
    Neurology; 2006 Oct 24; 67(8):1432-6. PubMed ID: 17060570
    [Abstract] [Full Text] [Related]

  • 17. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 24; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 18. GMFM 1 year after continuous intrathecal baclofen infusion.
    Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, McLaughlin JF, Nadell JM.
    Pediatr Rehabil; 2005 May 24; 8(3):207-13. PubMed ID: 16087555
    [Abstract] [Full Text] [Related]

  • 19. Intrathecal baclofen in the management of post-stroke hypertonia: current applications and future directions.
    Francisco GE.
    Acta Neurochir Suppl; 2007 May 24; 97(Pt 1):219-26. PubMed ID: 17691380
    [Abstract] [Full Text] [Related]

  • 20. Prospective 12-month study of intrathecal baclofen therapy for poststroke spastic upper and lower extremity motor control and functional improvement.
    Schiess MC, Oh IJ, Stimming EF, Lucke J, Acosta F, Fisher S, Simpson RK.
    Neuromodulation; 2011 Jan 24; 14(1):38-45; discussion 45. PubMed ID: 21992161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.